Cette traduction est en cours de préparation. En attendant, nous affichons temporairement la version originale en anglais.
Entreprise · 17/05/19991 min de lecture
Implantation or Injectable Dosage Form New Animal Drugs; Oxytetracycline Injection
Traduction automatique locale · Langue originale de la source
Résumé
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental abbreviated new animal drug application (ANADA) filed by Boehringer Ingelheim Vetmedica, Inc. The supplemental ANADA provides for establishment of a 28-day withdrawal period for subcutaneous use of oxytetracycline injection in cattle and for intramuscular use in swine.
Langue originale de la source: Federal Register — Food and Drug AdministrationOuvrir le communiqué original →